Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: John Posatiere who wrote (688)	12/16/1997 6:44:00 PM
From: Cisco	Read Replies (1) \| Respond to of 1894

John, I don't believe that is a change on Vector Securities or Pacific Crest Securities. Ever since I started following ACMI in Sept. each of these brokers listed a Buy rating. Different brokers use different rating systems. Zacks has always interpreted the buy recommendation from both Vector Securities and Pacific Crest Securities as Strong Buy (1.0) recommendations. For example some brokers 1.0 recommendation is a strong buy, a 2.0 is a buy, a 3.0 is a hold. Others use a buy as a 1.0, accumulate as a 2.0, and 3.0 as a hold. I have been checking Zacks at least once a week since Sept. and have never seen anything other than a buy from these two. I did notice that Hancock Institutional/Tucker Anthony's recommendation had expired on Zacks for being over 90 days old. Thanks for checking Zacks for me. I don't use the paid service because I am able to get most of what I want from Zacks free elsewhere. Cisco